Appleton Partners Inc Biomarin Pharmaceutical Inc Transaction History

Appleton Partners Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$74.77 - $85.47 $208,608 - $238,461	-2,790 Closed	0 $0
Q2 2021 Jul 07, 2021	SELL	$75.51 - $84.79 $47,948 - $53,841	-635 Reduced 18.54%	2,790 $233,000
Q1 2021 Apr 19, 2021	SELL	$74.73 - $90.69 $94,832 - $115,085	-1,269 Reduced 27.03%	3,425 $259,000
Q4 2020 Jan 19, 2021	SELL	$72.61 - $90.2 $180,435 - $224,147	-2,485 Reduced 34.61%	4,694 $412,000
Q3 2020 Oct 14, 2020	SELL	$71.87 - $131.03 $38,091 - $69,445	-530 Reduced 6.88%	7,179 $546,000

Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $76,845 - $119,996	966 Added 14.33%	7,709 $951,000
Q1 2020 May 04, 2020	BUY	$71.37 - $96.85 $43,036 - $58,400	603 Added 9.82%	6,743 $570,000
Q4 2019 Jan 13, 2020	BUY	$64.27 - $86.37 $33,099 - $44,480	515 Added 9.16%	6,140 $519,000
Q3 2019 Nov 04, 2019	SELL	$67.4 - $85.11 $52,909 - $66,811	-785 Reduced 12.25%	5,625 $379,000
Q2 2019 Jul 25, 2019	BUY	$80.35 - $93.9 $1,687 - $1,971	21 Added 0.33%	6,410 $549,000
Q1 2019 Apr 17, 2019	BUY	$84.2 - $98.62 $113,501 - $132,939	1,348 Added 26.74%	6,389 $568,000
Q4 2018 Jan 17, 2019	SELL	$80.14 - $106.07 $32,456 - $42,958	-405 Reduced 7.44%	5,041 $429,000
Q3 2018 Oct 09, 2018	BUY	$93.92 - $105.72 $102,936 - $115,869	1,096 Added 25.2%	5,446 $528,000
Q2 2018 Aug 08, 2018	BUY	$76.01 - $99.03 $330,643 - $430,780	4,350 New	4,350 $410,000

623

181M

1.73M

1.73M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $15.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Appleton Partners Inc, based on Form 13F filings with the SEC.

Stay updated on Appleton Partners Inc with notifications on news.